AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of the Chinese investigations remains minor.

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter ...

Belgium’s Deputy Prime Minister, Frank Vandenbroucke, called the EU’s joint health technology assessment a model of European cooperation, improving medicine evaluation, reducing costs, and ...

SandboxAQ today announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations ...

Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application directed ...

Among them were the reliability of Israel’s highly regarded intelligence force, Hamas’s alleged pragmatism since it rose to power, and the deeply entrenched assumption, held by parts of the Israeli ...

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

| With budget reconciliation right around the corner, different slices of the healthcare industry have made their views clear on issues like physician pay, ACA subsidies, telehealth flexibilities, ...

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...

A great opportunity to increase your skills in a senior capacity. You will provide a high standard of clinical assessment, treatment and support to clients of the St. Vincent’s integrated adult MHS ...

Greetings. Welcome to Mirion Technologies fourth quarter and full year 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...